CG
GILD icon

Curat Global’s Gilead Sciences GILD Stock Holding History

Curat Global’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
2,088
-2,992
-59% -$394K 0.38% 53
2026
Q1 		$708K Hold
5,080
– – 0.7% 33
2025
Q4 		$624K Hold
5,080
– – 0.69% 31
2025
Q3 		$565K Hold
5,080
– – 0.53% 44
2025
Q2 		$563K Hold
5,080
– – 0.54% 45
2025
Q1 		$569K Buy
+5,080
New +$524K 0.69% 40

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Curat Global's GILD Position: Q2 2026 in Review

Curat Global reduced its Gilead Sciences (GILD) stake by 59% in Q2 2026, selling an estimated $394K and leaving 2,088 shares worth $466K. The position accounts for 0.38% of the portfolio, ranked #53.

Curat Global first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $708K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Curat Global held 2,088 shares of Gilead Sciences worth $466K as of Q2 2026.
  • Curat Global sold 2,992 Gilead Sciences shares in Q2 2026, an estimated $394K.
  • Gilead Sciences made up 0.38% of Curat Global's portfolio in Q2 2026, its #53 holding.
  • Curat Global first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Curat Global's Gilead Sciences position peaked at $708K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.